HiFiBiO Therapeutics
Founded 2013 Β· 3 known investors
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
AI & Machine LearningBiotechHealthtech
Founders & leadership
HiFiBiO Therapeutics was founded in 2013 by Liang Schweizer.
LS
Liang SchweizerinFounder and President2025β2026
Investors Β· 3
.jpeg){kind=logo}
Frequently asked questions
- What does HiFiBiO Therapeutics do?
- HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
- Who founded HiFiBiO Therapeutics?
- HiFiBiO Therapeutics was founded by Liang Schweizer in 2013.
- Who are HiFiBiO Therapeutics's investors?
- HiFiBiO Therapeutics's investors include B Capital Group, B4 Capital, Trinity Innovation Bioventure Singapore.